COVID-19 Update | October 23, 2020

COVID-19 News

COVID-19 Update | October 23, 2020

October 23, 2020

The California Biotechnology Foundation is committed to keeping you up to date about COVID-19 testing, treatment and prevention advancements. The following resources track what progress has been made as of October 23, 2020. Notable advancements include:

  • The Food and Drug Administration approved Gilead Sciences’ antiviral drug remdesivir as a treatment for the coronavirus.
  • Pfizer Inc said it may file for U.S. authorization of its COVID-19 vaccine in late November if the vaccine is effective based on its 40,000 person clinical trial.
  • The National Institutes of Health launched a new trial of three companies’ immune modulator drugs to treat hospitalized COVID-19 patients: Johnson & Johnson, Bristol Myers Squibb and AbbVie.

​Recent News:

Rely on California Biotechnology Foundation to monitor breaking news and provide updates on the latest advancements in COVID-19 diagnostics, vaccines and treatments.

Stay informed on the latest news and trends on the economic and health benefits of this industry by visiting the new

If you have any questions about informational briefings contact California Biotechnology Foundation Executive Director Patty Cooper at (916)764-2434 or [email protected].